Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mirosław Wielgoś is active.

Publication


Featured researches published by Mirosław Wielgoś.


Annals of Transplantation | 2013

Prevalence of cervical high-risk human papillomavirus infections in kidney graft recipients

Natalia Mazanowska; Bronisława Pietrzak; Pawel Kaminski; Alicja Ekiel; Gayane Martirosian; Z. Jabiry-Zieniewicz; Mirosław Wielgoś

BACKGROUND Female kidney graft recipients are regarded as a group at risk of cervical cancer development. The objective of this study was to assess the prevalence of cervical high-risk human papilloma virus (HR-HPV) infection and cervical intraepithelial neoplasia (CIN) in female kidney graft recipients in comparison to healthy controls. MATERIAL AND METHODS We assessed the prevalence of HR-HPV and CIN in 60 female kidney graft recipients of reproductive age in outpatient care of the First Department of Obstetrics and Gynecology, Medical University of Warsaw. The control group consisted of 60 healthy women. Cervical swabs were analyzed with use of Amplicor HPV Roche Molecular Systems test, detecting DNA of 13 types of high-risk HPV: 6, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68. RESULTS HR-HPV was detected in 11/60 kidney recipients and 15/60 healthy women (p=0.37). There was no correlation between HR-HPV presence and immunosuppressive regimen, underlying disease, graft function, or time interval from transplantation. In both groups, higher prevalence of HR-HPV was observed in females with ≥2 lifetime sexual partners. Abnormal Pap test results in 2 kidney recipients (2 cases of HSIL) and 2 healthy women (LSIL and HSIL) required colposcopy-guided cervical biopsy, which in all cases revealed CIN2+. CONCLUSIONS Female kidney graft recipients seem to be equally exposed to cervical infection with HPV of high oncogenic potential as the healthy population.


BioMed Research International | 2016

Do We Pay Enough Attention to Culture Conditions in Context of Perinatal Outcome after In Vitro Fertilization? Up-to-Date Literature Review

Piotr Marianowski; Filip A. Dąbrowski; Aleksandra Zygula; Mirosław Wielgoś; Iwona Szymusik

Adverse perinatal outcomes in singleton IVF pregnancies have been most often explained by parental underlying diseases and so far laboratory conditions during embryo culture are still not explored well. The following review discusses the current state of knowledge on the influence of IVF laboratory procedures on the possible perinatal outcome. The role of improved media for human embryo culture is unquestionable. Addition of certain components to culture media and their effect on embryo survival and implantation rates have been taken into consideration recently and studied on animal model. Impact of media on perinatal outcome in IVF offspring has also been studied. It has been discovered that epigenetic changes and neonatal birth weight are probably associated with the use of specific culture media, as is the relation between placental size and its influence on perinatal outcome. There are still questions in the discussion about duration of embryo culture (cleavage stage versus blastocyst transfer). Some of the IVF methods, such as in vitro maturation of oocytes and freezing/thawing procedures, also require well-powered randomized controlled trials in order to define their exact impact on perinatal outcome. Constant further research is needed to assess the impact of laboratory environment on fetal and postnatal development.


Transplantation Proceedings | 2014

Intrauterine Growth Restriction in Pregnant Renal and Liver Transplant Recipients: Risk Factors Assessment

Anna Cyganek; Bronisława Pietrzak; Barbara Grzechocińska; T. Songin; B. Foroncewicz; K. Mucha; Mirosław Wielgoś

BACKGROUND Nowadays pregnancy after organ transplantation is possible due to advances in surgical and immunosuppressive therapies. One of the possible complications in pregnancy after organ transplantation is intrauterine growth restriction (IUGR). This may lead to various adverse perinatal outcomes. Prevalence of IUGR in the general population is estimated at 3%-10% with smoking being the most frequent maternal risk factor. The aim of this study was to determine the risk factors of IUGR in pregnant renal transplant recipients (RTR) or liver transplant recipients (LTR) in comparison with healthy pregnant women. METHODS Retrospective analysis included 48 RTR and 52 LTR. IUGR was defined as estimated fetal weight less than the 10th percentile for gestational age. IUGR was diagnosed in 15 (31.3%) pregnant RTR and in 10 (19.2%) LTR. The control group consisted of 60 healthy pregnant women diagnosed with IUGR. Fisher exact test and Student t test were used to assess the differences in fractions and means, respectively, between distinguished groups of patients. Test for fractions based on asymptotic normal distribution was used to compare the proportion of patients with IUGR with the proportion of 10% in the general population. The logistic regression model was used to assess the statistical significance of correlations between the assumed risk factors and the prevalence of IUGR in multivariate settings. RESULTS Hypertension, anemia, and proteinuria were the most frequent complications in the study group. They were more prominent in RTR than in LTR. Hypertension was diagnosed in all RTR, whereas severe anemia requiring erythropoietin treatment or blood transfusion was found in 4 RTR and in 1 LTR. CONCLUSION IUGR is more common in organ recipients. Therefore, vigilant obstetric care is highly recommended in pregnant patients after renal or liver transplantation. Hypertension, severe anemia, and proteinuria proved not to be statistically significantly correlated with the prevalence of IUGR among patients after transplantation.


Ginekologia Polska | 2016

First and third trimester serum concentrations of adropin and copeptin in gestational diabetes mellitus and normal pregnancy.

Filip A. Dąbrowski; Patrycja Jarmużek; Agata Gondek; Agnieszka Cudnoch-Jedrzejewska; Dorota Bomba-Opoń; Mirosław Wielgoś

OBJECTIVES Gestational diabetes mellitus (GDM) is a metabolic disease diagnosed in 1.7% up to 11.6% pregnancies. The prevalence of adverse pregnancy outcome is significantly higher in the case of early onset of diabetes mellitus. Adropin is a hormone promoting carbohydrate oxidation over fat oxidation, and influence nitric oxide synthase. Copeptin is a cleavage product of the vasopressin precursor recently correlated with diabetes mellitus. The aim of the study was to determine maternal serum adropin and copeptin concentrations in women with early and late manifestation of GDM and to discuss their potential role as biochemical markers of insulin resistance. MATERIAL AND METHODS Case-control study on 58 pregnant Caucasian women. Serum levels of adropin and copeptin were assessed in patients with early onset (GDM1) and classical gestational diabetes mellitus (GDM2). Complications such as macrosomia and hypotrophy were evaluated. RESULTS There was no significant difference between the study and the control group (age, BMI, parity). Fetal growth disturbance rate was 37.5% in GDM1, 11% in GDM2 and 6% in controls. Adropin concentration in GDM patients was significantly higher than in control group (p < 0.001), but there was no difference between GDM1 and GDM2 group. High serum concentration of adropin positively correlated with elevated HbA1c (p < 0.05). The groups did not differ in terms of copeptin serum concentration. CONCLUSIONS High adropin serum concentration in GDM patients is associated with increased risk of fetal growth disturbances, possibly due to improper placentation. According to our prospective study, neither copeptin nor adropin serum concentration are useful to discriminate between early and late onset of gestational diabetes mellitus.


International Journal of Gynecology & Obstetrics | 2015

Factors influencing the severity of pain during hysterosalpingography

Iwona Szymusik; Barbara Grzechocińska; Piotr Marianowski; Bartosz Kaczynski; Mirosław Wielgoś

To analyze factors influencing the severity of pain during hysterosalpingography (HSG).


Journal of Maternal-fetal & Neonatal Medicine | 2018

The influence of maternal vaginal flora on the intestinal colonization in newborns and 3-month-old infants

Iwona Gabriel; Anita Olejek; Krystyna Stencel-Gabriel; Mirosław Wielgoś

Abstract Aim: The role of maternal vaginal bacteria on the colonization of neonatal gut is still a matter of discussion. Our aim was to estimate the role of maternal vaginal flora on the development of intestinal flora in neonates and 3-month-old infants. Methods: Seventy-nine maternal–neonatal pairs were included in the study. Vaginal swabs were taken before the rupture of membranes after admission to the delivery ward. First neonatal stool (meconium) and stool at 3-month-old infants were collected and cultured. All samples were subjected to microbiological analysis for Streptococcus, Staphylococcus, Bifidobacterium, Clostridium (including C. difficile), Lactobacillus, Escherichia coli, Klebsiella pneumoniae, and Candida. Results: Maternal vagina was colonized mainly by streptococci (67%) followed by lactobacilli (58%) and Candida spp. (39%). Vaginal streptococci influenced the intestinal colonization in infants with staphylococci, C. difficile, and candida. Conclusion: Vaginal lactobacilli influenced colonization with C. difficile, and Candida. Vaginal flora is a potent factor influencing the development of bacterial flora in the neonatal and infantile gut. The extension of the observation period until 3 months of life allow to discover the potential changes in the intestinal flora of children.


Journal of Maternal-fetal & Neonatal Medicine | 2017

Lipoxin A4 (LXA4) as a potential first trimester biochemical marker of intrauterine growth disorders

Michał Lipa; Dorota Bomba-Opoń; Jacek Lipa; Pawel Bartnik; Zbigniew Bartoszewicz; Mirosław Wielgoś

Abstract Objective: To evaluate first trimester maternal serum levels of lipoxin A4 (LXA4) in prediction of intrauterine fetal growth. Methods: Study group of 185 patients in singleton pregnancy was divided into three subgroups according to neonatal birthweight: ≤10th percentile (SGA), 11–89th percentile (AGA) and ≥90 percentile (LGA). Results: We observed decreased values of LXA4 concentrations, both in SGA- and LGA groups, when compared to AGA (68.91 ± 33.72 and 68.30 ± 23.49 versus 102.13 ± 121.90, respectively). Conclusions: Lipoxin A4 may become an biochemical marker in the prediction of intrauterine fetal growth disturbances; however, more studies need to be undertaken to investigate LXA4’s role in pregnancy.


Ginekologia Polska | 2017

Towards a European Consensus on Gestational Diabetes Mellitus: A Pragmatic Guide for Diagnosis, Management, and Care. The Polish Diabetes in Pregnancy Study Group and FIGO.

Mirosław Wielgoś; Dorota Bomba-Opoń; Krzysztof Czajkowski; Ewa Wender-Ożegowska; Moshe Hod

Mirosław Wielgoś1, 2, Dorota Bomba-Opoń2, Krzysztof Czajkowski3, Ewa Wender-Ożegowska4, Moshe Hod5, 6 1President of Polish Gynecological Society 21st Chair and Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland 32nd Chair and Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland 4Chair of Obstetrics, Gynecology and Gynecologic Oncology, Department of Reproduction, Poznan University of Medical Sciences, Poland 5President European Association of Perinatal Medicine 6Chairman FIGO Working Group on Hyperglycemia in Pregnancy


Brain and behavior | 2017

Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis

Pawel Bartnik; Aleksandra Wielgoś; Joanna Kacperczyk; Katarzyna Pisarz; Iwona Szymusik; Aleksandra Podlecka-Piętowska; Beata Zakrzewska-Pniewska; Mirosław Wielgoś

Sexual dysfunction (SD) is one of the common symptoms of multiple sclerosis (MS) and is often underdiagnosed, especially in women. Relapsing‐remitting multiple sclerosis (RRMS) is the most widespread form of the disease, but the data on SD occurrence in this particular group of patients is limited. The aim of the study was to analyze the associations between demographic factors, symptoms and signs of MS, psychiatric comorbidities and SD in female patients with RRMS.


Ginekologia Polska | 2016

Assessment of the usefulness of pipelle biopsy in gynecological diagnostics

Szymon Piątek; Grzegorz Panek; Mirosław Wielgoś

OBJECTIVES The aim of this study is to assess the effectiveness of pipelle in sampling diagnostic material from the uterine cavity and determining clinical factors, which may affect its effectiveness. MATERIAL AND METHODS The retrospective analysis included 312 patients who underwent pipelle biopsy because of various indications. Evaluated factors which may affect the effectiveness of this method were: types of indications for the procedure, age, BMI, anteflexion or retroflexion of the uterus, presence of uterine fibroids, miscarriages, natural deliveries, deliveries in general. RESULTS In 259 (83.01%) cases sampled material allowed for a histopathological diagnosis. In 53 (16.99%) of the women we failed to sample tissue material from the uterine cavity. Indications for the procedure, BMI, age and menopausal status were factors of potential impact on the diagnostic effectiveness (p < 0.05). The diagnostic value of pipelle was found to be the lowest in women with overweight and obesity (BMI > 28), post-menopausal women, women over 55 years of age and where biopsy was performed for indications other than abnormal uterine bleeding. On the other hand, pipelle shows clearly the highest effectiveness in sampling diagnostic material from the uterine cavity in young women (< 45 years of age), menstruating women, women with normal body weight or underweight (BMI < 23) and abnormal uterine bleeding. CONCLUSIONS Choosing a pipelle as an endometrial biopsy method should consider the indications, BMI, age and menopausal status. Omission of these factors can increase non-diagnostic outcomes resulting in necessity of repeated biopsies, the risk of complications and increases the costs of health care system.

Collaboration


Dive into the Mirosław Wielgoś's collaboration.

Top Co-Authors

Avatar

Bronisława Pietrzak

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Dorota Bomba-Opoń

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Iwona Szymusik

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Dariusz Borowski

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Piotr Węgrzyn

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bartosz Czuba

Medical University of Silesia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Natalia Mazanowska

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Anna Cyganek

Medical University of Warsaw

View shared research outputs
Researchain Logo
Decentralizing Knowledge